Responses on the other five statements are recorded from 1 to 4
The companys most advanced candidate, axicabtagene ciloleucel (axi-cel), is a CAR-T therapy that at the time of the deal was under priority review by the FDA for refractory aggressive non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL)
More recently, agents within the GLP-1 receptor agonist class have also demonstrated cardiovascular and kidney benefits in completed cardiovascular outcome trials
Related Reading Do Genetics Affect How Long My Reproductive Years Will Last Ro Wegovy Mochi Wegovy Noom Wegovy Pricing and availability current as of July 2026
Novo Nordisk has announced that it has filed a lawsuit against Eli Lilly and Company in the United States, alleging that Lilly's advertising campaigns for its GLP-1 medicines are misleading and do not present complete scientific information
This study employed rigorous target trial emulation methodology, lending considerable credibility to its findings